# US 2021/0278367 A1 · Simultaneous detection of protein isoforms and nucleic acids from low starting cell numbers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0278367 A1
- Document ID: US20210278367A1
- Status: Published application
- Kind: A1
- Application number: 17/327,806
- Filed: 2021-05-24
- Published: 2021-09-09
- Earliest claimed: 2018-12-14
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Amy E. Herr; Lin He; Andrew J. Modzelewski; Elisabet Rosàs-Canyelles
- Web page: https://patentgrep.com/patent/US20210278367A1

## CPC

- G01N 27/44747: {Composition of gel or of carrier mixture}
- G01N 27/44782: {of a plurality of samples}
- C07K 1/26: Electrophoresis
- C08J 9/40: Impregnation
- C08K 5/1545: Six-membered rings
- C08L 33/26: Homopolymers or copolymers of acrylamide or methacrylamide
- C08J 2333/26: Homopolymers or copolymers of acrylamide or methacrylamide
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Dual nucleic acid and protein isoform measurements are performed on low starting cell numbers (e.g. equivalent to the number of blastomeres composing early embryonic development stages (morula and blastocysts)), comprising integrating fractionation polyacrylamide gel electrophoresis (fPAGE) of 10-100 cells with off-chip analysis of nucleic acids in the nuclei.

## Claims

### Claim 1

A polyacrylamide gel-based device that integrates electrophoretic separation of cytoplasmic proteins and extraction of nucleic acids from nuclei, the device comprising a polyacrylamide gel covalently grafted to a polyester film, wherein the gel comprises microwells and corresponding separation lanes, wherein each microwell contains fractionated nuclei of cells, and each corresponding separation lane comprises electrophoretically separated proteins of the cells.

### Claim 2 (depends on 1)

The device of claim 1, wherein each microwell abuts the corresponding separation lane.

### Claim 3 (depends on 1)

The device of claim 1, wherein each microwell is contained in an excised gel raft, wherein a void created by excision of the gel raft abuts the corresponding separation lane.

### Claim 4 (depends on 1)

The device of claim 1, wherein each microwell is contained in an excised gel raft, wherein a void created by excision of the gel raft abuts the corresponding separation lane, and each gel raft is contained in a reaction vessel wherein nucleic acid from then nuclei is extracted.

### Claim 5 (depends on 1)

The device of claim 1, wherein the proteins are photocaptured by UV-light activated benzophenone moieties incorporated in the gel.

### Claim 6 (depends on 1)

The device of claim 1 wherein the gel is 100-150 μm-thick, and the microwells are cylindrical of diameters of 20-160 μm.

### Claim 7 (depends on 1)

The device of claim 1 wherein each microwell contains fractionated nuclei of 1-100 cells.

### Claim 8 (depends on 1)

The device of claim 1 wherein each microwell contains fractionated nuclei of 10-100 cells.

### Claim 9 (depends on 1)

The device of claim 1, further comprising a membrane comprising a transverse electrophoretic protein blot of the gel.

### Claim 10 (depends on 1)

The device of claim 1 wherein each microwell contains fractionated nuclei of cells, wherein the cells are of a biopsy.

### Claim 11 (depends on 1)

The device of claim 1 wherein each microwell contains fractionated nuclei of cells, wherein the cells are of a single embryo or single blastomere.

### Claim 12 (depends on 2)

The device of claim 2 wherein each microwell contains fractionated nuclei of cells, wherein the cells are of a single embryo or single blastomere.

### Claim 13 (depends on 3)

The device of claim 3 wherein each microwell contains fractionated nuclei of cells, wherein the cells are of a single embryo or single blastomere.

### Claim 14 (depends on 4)

The device of claim 4 wherein each microwell contains fractionated nuclei of cells, wherein the cells are of a single embryo or single blastomere.

### Claim 15 (depends on 5)

The device of claim 5 wherein each microwell contains fractionated nuclei of cells, wherein the cells are of a single embryo or single blastomere.

### Claim 16 (depends on 6)

The device of claim 6 wherein each microwell contains fractionated nuclei of cells, wherein the cells are of a single embryo or single blastomere.

### Claim 17 (depends on 7)

The device of claim 7 wherein each microwell contains fractionated nuclei of cells, wherein the cells are of a single embryo or single blastomere.

### Claim 18 (depends on 8)

The device of claim 8 wherein each microwell contains fractionated nuclei of cells, wherein the cells are of a single embryo or single blastomere.

### Claim 19 (depends on 9)

The device of claim 9 wherein each microwell contains fractionated nuclei of cells, wherein the cells are of a single embryo or single blastomere.

### Claim 20 (depends on 1)

A method integrating electrophoretic separation of cytoplasmic proteins and extraction of nucleic acids from nuclei using the device of claim 1, the method comprising
performing on the contained nuclei a genomic or transcriptomic measurement; and
performing on the separated proteins a protein measurement.
